First small molecular inhibitors of T. brucei dolicholphosphate mannose synthase (DPMS), a validated drug target in African sleeping sickness.
about
Recent pharmacological developments on rhodanines and 2,4-thiazolidinedionesAssessing the trypanocidal potential of natural and semi-synthetic diketopiperazines from two deep water marine-derived fungi.Lipid metabolism in Trypanosoma bruceiChemical biology of glycosylphosphatidylinositol anchors.Novel 4-Thiazolidinone Derivatives as Anti-Infective Agents: Synthesis, Characterization, and Antimicrobial EvaluationRecent developments with rhodanine as a scaffold for drug discovery.
P2860
First small molecular inhibitors of T. brucei dolicholphosphate mannose synthase (DPMS), a validated drug target in African sleeping sickness.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 30 January 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
First small molecular inhibito ...... in African sleeping sickness.
@en
First small molecular inhibito ...... in African sleeping sickness.
@nl
type
label
First small molecular inhibito ...... in African sleeping sickness.
@en
First small molecular inhibito ...... in African sleeping sickness.
@nl
prefLabel
First small molecular inhibito ...... in African sleeping sickness.
@en
First small molecular inhibito ...... in African sleeping sickness.
@nl
P2093
P2860
P921
P1476
First small molecular inhibito ...... in African sleeping sickness.
@en
P2093
Benjamin L Young
David L Hughes
Gerd K Wagner
Helen Denton
Terry K Smith
P2860
P304
P356
10.1016/J.BMCL.2009.01.083
P407
P577
2009-01-30T00:00:00Z